CERo Therapeutics (NASDAQ:CERO) Earns “Hold” Rating from D. Boral Capital
CERo Therapeutics (NASDAQ:CERO – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at D. Boral Capital in a research report issued on Friday,Benzinga reports. A number of other analysts have also recently weighed in on the company. D Boral Capital raised CERo Therapeutics to a “strong-buy” rating in a research […]
CERo Therapeutics (NASDAQ:CERO – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at D. Boral Capital in a research report issued on Friday,Benzinga reports. A number of other analysts have also recently weighed in on the company. D Boral Capital raised CERo Therapeutics to a “strong-buy” rating in a research […]
